FAM114A2
Protein FAM114A2
Also known as: 133K02, C5orf3, F1142_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRY5
- Gene
- FAM114A2
- Ensembl
- ENSG00000055147
- Chromosome
- 5
- Canonical length
- 505 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Predicted to enable purine nucleotide binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
505 residues, UniProt reviewed canonical sequence.
>Q9NRY5|FAM114A2
1 MSDKDDIETP LLTEAAPILE DGNCEPAKNS ESVDQGAKPE SKSEPVVSTR KRPETKPSSD
61 LETSKVLPIQ DNVSKDVPQT RWGYWGSWGK SILSSASATV ATVGQGISNV IEKAETSLGI
121 PGPSEISTEV KYVAGETNAK ENENSSPVAG AFGVFSTIST AVQSTGKSVI SGGLDALEFI
181 GKKTMDVIAE GDPGFKRTKG LMNRNATLSQ VLREAKEKEE IRTSNEVTVE TDKKTHYGLL
241 FDEFQGLSHL EALEMLSQES EIKVKSILNS LSGEELETLK VELEQLKETF SLAEFCEEEE
301 EEKKGDEDFT KDITELFSQL HVSSKPEKLA RARNTAHEWI RKSLTKPLAE NEEGEKQSEA
361 ENTEQVNKNS IEDIHAFAIR SLAELTACSI ELFHKTAALV LHGRKQEVTA IERSQTLSQM
421 TIVLCKELSS LSKEFTTCLT TAGVKEMADV LNPLITAVFL EASNSASYIQ DAFQLLLPVL
481 EISLIENKIE SHRHELQGQK PLLEHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM114A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- testis: 35 nTPM
- parathyroid gland: 21 nTPM
- skeletal muscle: 19 nTPM
- heart muscle: 18 nTPM
- tonsil: 16 nTPM
- epididymis: 16 nTPM
Single-cell type
- early primary spermatocytes: 106 nCPM
- late primary spermatocytes: 100 nCPM
- early spermatids: 47 nCPM
- differentiating spermatogonia: 41 nCPM
- erythrocyte progenitors: 40 nCPM
- pancreatic acinar cells: 38 nCPM
Immune cell
- basophil: 38 nTPM
- eosinophil: 36 nTPM
- non-classical monocyte: 23 nTPM
- intermediate monocyte: 18 nTPM
- memory CD8 T-cell: 18 nTPM
- naive B-cell: 18 nTPM
Brain region
- thalamus: 23 nTPM
- hypothalamus: 22 nTPM
- choroid plexus: 21 nTPM
- midbrain: 20 nTPM
- pons: 20 nTPM
- medulla oblongata: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.38
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FAM114A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM114A2 as an antibody target. Whether an autoantibody or antibody against FAM114A2 could matter depends on whether native FAM114A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM114A2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM114A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...